Hims & Hers (HIMS) Form 144: 900 Class A Shares Planned Sale
Hims & Hers Health, Inc. notice reports a proposed sale of 900 Class A shares through Fidelity Brokerage Services LLC on 10/10/2025 with an aggregate market value of $52,425.
Rhea-AI Filing Summary
Hims & Hers Health, Inc. notice reports a proposed sale of 900 Class A shares through Fidelity Brokerage Services LLC on 10/10/2025 with an aggregate market value of $52,425. The filer indicates the shares derive from an option granted on 08/10/2022 and show cash payment on the stated sale date. The filing lists recent insider sales by Michael Y. Chi totaling $4,240,268.50 across eight transactions between 07/23/2025 and 10/01/2025.
The notice includes the required representation that the seller does not possess undisclosed material adverse information and identifies this as a Rule 144 notice of proposed sale. No earnings, guidance, or other operational metrics are disclosed in this form.
Positive
- Transparency of planned sale via Form 144 with broker and sale date disclosed
- Shares originate from documented option grant (granted 08/10/2022) showing standard vesting/exercise mechanics
Negative
- Multiple recent insider sales totaling $4,240,268.50 may signal ongoing insider liquidity needs
- Filing lacks contextual disclosure about purpose of sales or holdings post-transaction
Insights
TL;DR: A small scheduled Rule 144 sale (900 shares) follows multiple recent insider dispositions totaling over $4.24M.
The filing documents a planned disposal of 900 Class A shares on 10/10/2025 via Fidelity Brokerage Services LLC. The shares stem from an option granted on 08/10/2022 and are slated to be paid in cash, consistent with routine option exercise-and-sale activity.
Recent recorded sales by Michael Y. Chi span eight transactions from 07/23/2025 to 10/01/2025, with aggregate gross proceeds of $4,240,268.50, which is relevant for monitoring ongoing insider liquidity but is not a regulatory finding. Monitor near-term insider selling volumes and any public disclosures that provide context within 30 days.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does the HIMS Form 144 disclose about the proposed sale?
Does the Form 144 state the seller has undisclosed material information?
Which exchange will the proposed sale occur on?
AI-generated analysis. How Rhea-AI works. Not financial advice.